COVID-19: Vaccines and Therapeutics
The Food and Drug Administration鈥檚 Vaccines and Related Biological Products Advisory Committee by a unanimous vote recommended that the FDA issue an emergency use authorization that would enable COVID-19 vaccine boosters for individuals age 65 and older and those at high risk for severe COVID-19,鈥
Inspiring nurse joins COVID-19 task force and launches community vaccination team.
As COVID-19 care demands 鈥渙utstrip resources鈥 at some Idaho hospitals, health care leaders came together to discuss how they are addressing the crisis and reiterate the solution: vaccination.
Saline Health CEO says vaccine strategies must 鈥渟tart with the heart.鈥
The Centers for Disease Control and Prevention revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19 vaccines, with Moderna鈥檚 vaccine deemed most effective at preventing hospitalizations.
The Department of Health and Human Services鈥 Assistant Secretary for Preparedness and Response announced a major change in the distribution of COVID-19 monoclonal antibody therapies.
The Department of Health and Human Services鈥 (HHS) Assistant Secretary for Preparedness and Response (ASPR) Sept. 13 announced a major change in the distribution of COVID-19 monoclonal antibody therapies.
The AHA has received a $1 million grant from the Centers for Disease Control and Prevention to continue for one year its efforts to encourage COVID-19 vaccine confidence in the hospital field, clinicians and the public.
A pair of peer-reviewed studies published in the New England Journal of Medicine are affirming the safety and effectiveness of Pfizer鈥檚 COVID-19 vaccine, first at six months following a completed, two-dose regimen, and then with boosters.
The 黑料正能量 Association (AHA) announced that the organization received $1 million in grant funding from the Centers for Disease Control and Prevention (CDC) to continue COVID-19 vaccine confidence efforts through September 2022.